Drug Plans Regulation, B.C. Reg. 73/2015

Section 32

End of enrolment in MDPO

Cite as Drug Plans Regulation, B.C. Reg. 73/2015, s. 32 · last amended March 1, 2026 · read from BC Laws on November 17, 2026

The text

(1) A family unit's enrolment in the MDPO ends on the earliest of the following dates: (a) December 31; (b) if the registrant gives notice to the minister stating the registrant's desire to cancel the enrolment of the registrant's family unit in the MDPO, on the later of (i) the date stated in the notice, if any, and (ii) the date the notice is received by the minister; (c) on the date set by the minister on cancelling the family unit's enrolment in the MDPO. (2) The minister may cancel the enrolment of a family unit in the MDPO in any of the following circumstances: (a) if a member of the family unit commits an offence under the Act; (b) if (i) the minister gives notice to the family unit that family unit owes an amount equalling 3 or more monthly instalments, excluding interest or fees, if any, and (ii) the family unit does not pay the full amount owing within 30 days of the time stated in the notice; (c) if the family unit has failed, as of March 1, to pay an amount owing toward a monthly instalment that (i) was due in the previous year, and (ii) totals more than $10. (3) A family unit must, immediately on the end of enrolment in the MDPO, pay all amounts, including interest and fees, if any, owing toward monthly instalments. (4) The total amount that a person is liable to pay under subsection (3) is a debt due to the government and may be (a) deducted from any subsequent payment that may be made to the person under the Act, or (b) recovered in a court of competent jurisdiction. (5) On the end of enrolment in the MDPO, the minister must pay to the person who enrolled a family unit in the MDPO the amount by which the family unit's monthly instalment payments exceeded the cost of benefits paid by the minister under the Act, if that amount is $5 or more.
Read the Drug Plans Regulation on BC Laws ↗

Made under Pharmaceutical Services Act, SBC 2012, c. 22.